Exogenus Therapeutics has over 10 years of combined experiencein development of Extracellular Vesicles (EV) and othernanoparticle-based products. As a recognized leader in the field ofEV, our team has advanced skills to support all the R&D activitiesnecessary for the transition of EV technologies to the market,spanning from clinical solutions to everyday use products.Additionally, our multidisciplinary team has strong capabilities for thedevelopment of other RNA and DNA-based products (with syntheticand biological nanoparticles), and their combination withfunctionalized biomaterials, enabling the development of moreefficient and smart delivery systems. Exogenus aims to leverage itsinterdisciplinary expertise to support the development ofnanoparticle-based technologies, driving the next generation ofnanoproducts innovations. To know more
